Cubist Pharmaceuticals, Inc.

Cubicin maker completes $120 million financing

Published in Health Business Week, December 31st, 2004

Cubist Pharmaceuticals, Inc., (CBST) announced the completion of its public offering of 9,316,700 shares of Cubist common stock at $11.20 per share.

The company also announced that the underwriters of this offering exercised in full their option to purchase an additional 1,397,500 shares of Cubist common stock at $11.20 per share. Gross proceeds of approximately $120 million represent a 20% increase over the original shelf registration statement previously filed with the U.S. Securities and Exchange Commission.

Proceeds to Cubist from this offering, net of underwriting discounts and commissions, and estimated offering expenses, totaled $112.5...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Health Business Week

Source: Health Business Week (2004-12-31)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry